unknown
Stage
2018
Founded
1
Investors
About
HEPHAISTOS Pharma develops ONCO-Boost, a natural TLR4 agonist designed to stimulate patients' innate and adaptive immune systems to improve anti-tumor responses against immunologically cold tumors.
Explore HEPHAISTOS Pharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.